Semaglutide & GLP-1 Weight-Loss Laws by State (2026)
Two things decide whether you can legally run a semaglutide or GLP-1 weight-loss program: the federal rules on where the drug comes from, and your state's rules on who can prescribe it. Start with the federal compounding status below, then pick your state for who can prescribe, whether the state's weight-loss prescribing rules reach GLP-1, and whether telehealth prescribing is settled there.
Compounded semaglutide and tirzepatide: mostly off the table now
This part is federal, not state-by-state, and it changed recently. The FDA declared the semaglutide and tirzepatide shortages resolved, which ended the mass-compounding exception those shortages allowed. As of the July 2026 review, compounding these drugs is limited to narrow, patient-specific circumstances, so most programs have to use the FDA-approved branded products. This is enforced by the FDA and is still moving, so confirm the current status before you build a program around compounded product.
What is true in every state
- Prescribing GLP-1 is the practice of medicine
- A licensed prescriber has to evaluate the patient and prescribe. There is no 'fill out a form and get a script': a real good-faith exam and a genuine provider-patient relationship are required everywhere.
- The drug has to be sourced legitimately
- That means an FDA-approved branded product, or lawful compounding within the narrow current exceptions. Mass-compounded semaglutide from the shortage era is largely no longer permitted.
- Estheticians and unlicensed staff do not prescribe
- Prescribing is for physicians, NPs, and PAs within their authority. Estheticians, cosmetologists, and other unlicensed staff cannot prescribe or decide who gets the medication.
- Who injects is broader than who prescribes
- A subcutaneous injection can usually be given by an RN, an LPN, or a medical assistant under delegation, on the prescriber's order. The prescribing decision, not the injection, is the regulated bottleneck.
- Most 'weight-loss rules' are about phentermine, not GLP-1
- Many states have prescribing rules for weight-reduction drugs, but they were written for controlled-substance appetite suppressants and generally don't reach GLP-1s, which aren't controlled. The lookup flags the rare state whose rule does reach GLP-1.
Reviewed July 2026. This is general information, not legal advice, and this area is moving quickly, the federal compounding rules especially. Confirm the current federal status with the FDA and your state medical board, and talk to a healthcare attorney, before you build or change a weight-loss program.
The federal question comes first: where the drug comes from
Before any state rule matters, there is a federal one that reshaped this whole business. During the shortage, pharmacies could compound semaglutide and tirzepatide, and a wave of low-cost programs was built on that. The FDA has since declared those shortages resolved, which ended the exception that allowed mass compounding. As of this review, compounding these drugs is limited to narrow, patient-specific situations, so most programs now have to dispense the FDA-approved branded products.
This is national, not state-by-state, and it is still moving, so the tool shows it first and dated. If your program was built on compounded product, this is the part to confirm before anything else.
Then the state question: who can prescribe
Prescribing GLP-1 for weight loss is the practice of medicine, so a licensed prescriber has to evaluate the patient and write the order. A physician can do that in every state. Whether a nurse practitioner or PA can prescribe on their own depends on the state's practice-authority rules: in a full-practice-authority state a nurse practitioner can run the prescribing side, and in the rest they need a collaborating or supervising physician. Because GLP-1s are not controlled substances, this tracks the state's general nurse-practitioner prescribing authority rather than any special scheduling rule.
Some states go further and have specific rules for prescribing medication for weight reduction, left over from the era of appetite suppressants, covering exams, patient relationships, and limits. The lookup flags the states that have those, and the ones that require an in-person visit before prescribing.
How this fits with your other med-spa rules
A weight-loss program sits inside the wider question of who can own and run a medical practice in your state, and who can perform the medical services. If you also offer injectables, lasers, or IV therapy, the ownership, supervision, and administration rules for those matter alongside the prescribing rules here.
The med spa laws by state lookup covers ownership and medical direction, and the IV therapy laws by state lookup covers who can order and administer IV drips. Read them together, and confirm all of it with your state boards and a healthcare attorney.
Frequently asked questions
Is compounded semaglutide still legal?
Mostly not, as of the July 2026 review, and this is a federal question rather than a state one. The FDA declared the semaglutide and tirzepatide shortages resolved, which ended the mass-compounding exception the shortages had allowed. Compounding these drugs is now limited to narrow, patient-specific circumstances, so most weight-loss programs have to use the FDA-approved branded products. The rules here are still moving, so confirm the current federal status before building a program around compounded product.
Who can prescribe semaglutide for weight loss?
A physician can everywhere, and whether a nurse practitioner or PA can prescribe on their own depends on your state. In a full-practice-authority state a nurse practitioner can evaluate, diagnose, and prescribe GLP-1 medication independently; in the rest they need a collaborating or supervising physician. GLP-1s are not controlled substances, so this tracks the state's general nurse-practitioner prescribing authority. The lookup shows which applies in your state, plus whether the state has specific weight-loss prescribing rules.
Can you prescribe semaglutide through telehealth?
Usually yes, since GLP-1s are not controlled substances and so are not subject to the in-person rules that apply to controlled-substance telehealth prescribing. A valid patient evaluation and a genuine provider-patient relationship are still required, which a synchronous video visit can establish in most states. A couple of states are unsettled, where the board expects a history and physical exam that may need to be in person, so the lookup flags telehealth as settled or not for your state.
Do you need a doctor to run a semaglutide weight-loss business?
It depends on your state's nurse-practitioner rules and how you structure it. In a full-practice-authority state a nurse practitioner can run the prescribing side; elsewhere you need a collaborating or supervising physician, so that relationship has to be built into the business. On top of that, prescribing is the practice of medicine everywhere, so a real exam is required, the drug has to be sourced legitimately, and any state weight-loss prescribing rules apply. Confirm the setup with a healthcare attorney before you open.